AXSOME THERAPEUTICS, INC. — Net Income by Fiscal Year
12 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/e1a8691b-819a-4be8-8646-6d789235da97/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-183.2M | 2025-01-01 – 2025-12-31 | evidence 0001193125-26-064267 |
| FY 2024 | $-287.2M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-022457 |
| FY 2023 | $-239.2M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-019118 |
| FY 2022 | $-187.1M | 2022-01-01 – 2022-12-31 | evidence 0000950170-24-019118 |
| FY 2021 | $-130.4M | 2021-01-01 – 2021-12-31 | evidence 0000950170-24-019118 |
| FY 2020 | $-102.9M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-009924 |
| FY 2019 | $-68.3M | 2019-01-01 – 2019-12-31 | evidence 0001558370-20-002573 |
| FY 2018 | $-31.0M | 2018-01-01 – 2018-12-31 | evidence 0001558370-19-002068 |
| FY 2017 | $-28.9M | 2017-01-01 – 2017-12-31 | evidence 0001558370-18-001639 |
| FY 2016 | $-27.2M | 2016-01-01 – 2016-12-31 | evidence 0001558370-17-001426 |
| FY 2015 | $-12.2M | 2015-01-01 – 2015-12-31 | evidence 0001558370-17-001426 |
| FY 2014 | $-6.0M | 2014-01-01 – 2014-12-31 | evidence 0001558370-17-001426 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
AXSOME THERAPEUTICS, INC. — all facts · Revenue · Operating Income